Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000579023 | SCV000681198 | likely pathogenic | not provided | 2017-12-07 | criteria provided, single submitter | clinical testing | The S14926X variant in the TTN gene has not been reported as a pathogenic or benign to our knowledge. S14926X is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Other truncating TTN variants have been reported in approximately 3% of control alleles (Herman et al., 2012). However, S14926X is located in the A-band region of titin, where the majority of truncating pathogenic variants associated with DCM have been reported (Herman et al., 2012). Furthermore, the S14926X variant is not observed in large population cohorts (Lek et al., 2016). |